Article Details
Retrieved on: 2021-06-24 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company said Roche requested that 4D Molecular end the Roche-funded 4D-110 trial in advanced choroideremia patients as a result of Roche's ...
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here